Source: Annals of Oncology,. Conference titles: ESMO Congress. Unidade: FM
Subjects: GÂNGLIOS LINFÁTICOS (PATOLOGIA), NEOPLASIAS MAMÁRIAS (QUIMIOTERAPIA), QUIMIOTERAPIA ADJUVANTE
ABNT
CASTRO, Gilberto et al. Axillary lymph node involvement at diagnosis can predict persistent nodal disease after neoadjuvant chemotherapy (neoCT) in brasilian patients (pts) with breast cancer (BC). Annals of Oncology,. Oxford: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 11 maio 2024. , 2002APA
Castro, G., Snitcovsky, I. M. L., Diz, M. P. E., Folgueira, M. A. K., Carelli, G., Bertoni, V. D., et al. (2002). Axillary lymph node involvement at diagnosis can predict persistent nodal disease after neoadjuvant chemotherapy (neoCT) in brasilian patients (pts) with breast cancer (BC). Annals of Oncology,. Oxford: Faculdade de Medicina, Universidade de São Paulo.NLM
Castro G, Snitcovsky IML, Diz MPE, Folgueira MAK, Carelli G, Bertoni VD, Siqueira SAC, Carvalho FM, Brentani MM, Federico MHH. Axillary lymph node involvement at diagnosis can predict persistent nodal disease after neoadjuvant chemotherapy (neoCT) in brasilian patients (pts) with breast cancer (BC). Annals of Oncology,. 2002 ; 13 42.[citado 2024 maio 11 ]Vancouver
Castro G, Snitcovsky IML, Diz MPE, Folgueira MAK, Carelli G, Bertoni VD, Siqueira SAC, Carvalho FM, Brentani MM, Federico MHH. Axillary lymph node involvement at diagnosis can predict persistent nodal disease after neoadjuvant chemotherapy (neoCT) in brasilian patients (pts) with breast cancer (BC). Annals of Oncology,. 2002 ; 13 42.[citado 2024 maio 11 ]